Based on this background of evidence, the two main aims of this multi‐centre, cross‐sectional study, which included adults with T1DM undergoing vibration‐controlled transient elastography (VCTE) with liver stiffness measurement (LSM) and controlled attenuation parameter (CAP) to non‐invasively measure hepatic fibrosis and steatosis, were as follows: (a) to examine the prevalence of MASLD and significant fibrosis; and (b) to assess the association of MASLD with insulin sensitivity, as non‐invasively estimated by glucose disposal rate (eGDR) and continuous glucose monitoring metrics. Here, INS is linked to Hepatic fibrosis.